Universal Ibogaine Inc Statistics
Universal Ibogaine Inc (JC4) Stock Statistics & Valuation Metrics
Total Valuation
Universal Ibogaine Inc has a market cap or net worth of EUR 871.43K. The enterprise value is EUR 4.01T.
- Market Cap
- EUR 871.43K
- Enterprise Value
- EUR 4.01T
Share Statistics
Universal Ibogaine Inc has 274,825,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 274,825,740
- Owned by Insiders
- 1.98%
- Owned by Institutions
- ―
Financial Efficiency
Universal Ibogaine Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- ―
- Employee Count
- 0
- Asset Turnover
- ―
- Inventory Turnover
- ―
Valuation Ratios
The current PE Ratio of Universal Ibogaine Inc is -0.50. Universal Ibogaine Inc’s PEG ratio is -0.01.
- PE Ratio
- -0.50
- PS Ratio
- 0.67
- PB Ratio
- 1.17
- Price to FCF
- -1.71
- Price to Operating Cash Flow
- -1.39
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Universal Ibogaine Inc had revenue of 2.33M and earned -2.05M in profits. Earnings per share was -0.01.
- Revenue
- 2.33M
- Gross Profit
- 2.33M
- Operating Income
- 551.66K
- Pretax Income
- -2.05M
- Net Income
- -2.05M
- EBITDA
- -1.54M
- Earnings Per Share (EPS)
- -0.01
Cash Flow
In the last 12 months, operating cash flow was -642.80K and capital expenditures -20,690, giving a free cash flow of -663.50K billion.
- Operating Cash Flow
- -642.80K
- Free Cash Flow
- -663.50K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Universal Ibogaine Inc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -58.63%
- Earnings Yield
- -176.48%
Stock Price Statistics
- Beta
- 1.21
- 52-Week Price Change
- -12.50%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- 1,339
Important Dates
Universal Ibogaine Inc upcoming earnings date is Dec 02, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Jun 26, 2026
- Next Earnings Date
- Dec 02, 2026
- Ex-Dividend Date
- ―
Taxes
In the past 12 months, Universal Ibogaine Inc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- ―
Enterprise Valuation
Universal Ibogaine Inc EV to EBITDA ratio is -2.50, with an EV/FCF ratio of -4.19.
- EV to Sales
- 1.65
- EV to EBITDA
- -2.50
- EV to Free Cash Flow
- -4.19
- EV to Operating Cash Flow
- -4.59
Balance Sheet
Universal Ibogaine Inc has EUR 127.75K in cash and marketable securities with EUR 2.57M in debt, giving a net cash position of -EUR 2.44M billion.
- Cash & Marketable Securities
- EUR 127.75K
- Total Debt
- EUR 2.57M
- Net Cash
- -EUR 2.44M
- Net Cash Per Share
- -EUR 0.01
- Tangible Book Value Per Share
- EUR 0.00
Margins
Gross margin is 100.00%, with operating margin of 23.67%, and net profit margin of -88.01%.
- Gross Margin
- 100.00%
- Operating Margin
- 23.67%
- Pretax Margin
- -88.01%
- Net Profit Margin
- -88.01%
- EBITDA Margin
- -66.03%
- EBIT Margin
- -80.76%
